Page last updated: 2024-11-07

methylprednisolone acetate and Retinal Artery Occlusion

methylprednisolone acetate has been researched along with Retinal Artery Occlusion in 1 studies

Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.

Retinal Artery Occlusion: Sudden ISCHEMIA in the RETINA due to blocked blood flow through the CENTRAL RETINAL ARTERY or its branches leading to sudden complete or partial loss of vision, respectively, in the eye.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, V1
Sharma, SC1
Gupta, A1
Dogra, MR1

Other Studies

1 other study available for methylprednisolone acetate and Retinal Artery Occlusion

ArticleYear
Retinal and choroidal microvascular embolization with methylprednisolone.
    Retina (Philadelphia, Pa.), 2002, Volume: 22, Issue:3

    Topics: Adult; Choroid; Choroid Diseases; Drainage; Embolism; Female; Glucocorticoids; Hemangioma; Humans; I

2002